{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:52:13Z","timestamp":1785851533653,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11060-024-04878-x","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T19:36:15Z","timestamp":1731526575000},"page":"609-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of adjuvant radiation treatment following subtotal resection of world health organization grade II meningiomas"],"prefix":"10.1007","volume":"171","author":[{"given":"Jordan C.","family":"Petitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Murayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"El-Abtah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arbaz","family":"Momin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Halima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamia","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ahorukomeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Jarmula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihika","family":"Thapliyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo F.","family":"Recinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun R.","family":"Kshettry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"Suppl 4","key":"4878_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro Oncol 17:iv1\u2013iv62. https:\/\/doi.org\/10.1093\/neuonc\/nov189","journal-title":"Neuro Oncol"},{"key":"4878_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"4878_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","volume":"128","author":"M Lambrecht","year":"2018","unstructured":"Lambrecht M, Eekers DBP, Alapetite C et al (2018) Radiation dose constraints for organs at risk in neuro-oncology; the European particle therapy network consensus. Radiother Oncol 128:26\u201336. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.001","journal-title":"Radiother Oncol"},{"issue":"2","key":"4878_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.radonc.2018.06.018","volume":"128","author":"DC Weber","year":"2018","unstructured":"Weber DC, Ares C, Villa S et al (2018) Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042\u201326042). Radiother Oncol 128(2):260\u2013265. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.018","journal-title":"Radiother Oncol\u00a0"},{"key":"4878_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","volume":"16","author":"MD Jenkinson","year":"2015","unstructured":"Jenkinson MD, Javadpour M, Haylock BJ et al (2015) The ROAM\/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials 16:519. https:\/\/doi.org\/10.1186\/s13063-015-1040-3","journal-title":"Trials\u00a0"},{"issue":"4","key":"4878_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.rpor.2016.03.007","volume":"21","author":"P Fossati","year":"2016","unstructured":"Fossati P, Vavassori A, Deantonio L, Ferrara E, Krengli M, Orecchia R (2016) Review of photon and proton radiotherapy for skull base tumours. Rep Pract Oncol Radiother 21(4):336\u2013355. https:\/\/doi.org\/10.1016\/j.rpor.2016.03.007","journal-title":"Rep Pract Oncol Radiother\u00a0"},{"issue":"2","key":"4878_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2012.12.JNS12414","volume":"119","author":"DA Hardesty","year":"2013","unstructured":"Hardesty DA, Wolf AB, Brachman DG et al (2013) The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119(2):475\u2013481. https:\/\/doi.org\/10.3171\/2012.12.JNS12414","journal-title":"J Neurosurg\u00a0"},{"issue":"4","key":"4878_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuchi.2017.03.004","volume":"63","author":"C Champeaux","year":"2017","unstructured":"Champeaux C, Houston D, Dunn L (2017) Atypical meningioma. A study on recurrence and disease-specific survival. Neurochirurgie 63(4):273\u2013281. https:\/\/doi.org\/10.1016\/j.neuchi.2017.03.004","journal-title":"Neurochirurgie\u00a0"},{"issue":"4","key":"4878_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1227\/00006123-198704000-00003","volume":"20","author":"NM Barbaro","year":"1987","unstructured":"Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM (1987) Radiation therapy in the treatment of partially resected meningiomas. Neurosurg 20(4):525\u2013528. https:\/\/doi.org\/10.1227\/00006123-198704000-00003","journal-title":"Neurosurg\u00a0"},{"key":"4878_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-12-822198-3.00046-X","volume":"170","author":"S Chao","year":"2020","unstructured":"Chao S, Rogers L (2020) External beam radiation therapy for meningioma. Handb Clin Neurol 170:259\u2013278. https:\/\/doi.org\/10.1016\/B978-0-12-822198-3.00046-X","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"4878_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-013-1219-y","volume":"115","author":"HJ Park","year":"2013","unstructured":"Park HJ, Kang HC, Kim IH et al (2013) The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115(2):241\u2013247. https:\/\/doi.org\/10.1007\/s11060-013-1219-y","journal-title":"J Neurooncol\u00a0"},{"issue":"5","key":"4878_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1227\/NEU.0b013e3181f2f427","volume":"67","author":"CY Choi","year":"2010","unstructured":"Choi CY, Soltys SG, Gibbs IC et al (2010) Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurg 67(5):1180\u20131188. https:\/\/doi.org\/10.1227\/NEU.0b013e3181f2f427","journal-title":"Neurosurg\u00a0"},{"issue":"2","key":"4878_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11060-021-03711-z","volume":"152","author":"AA Momin","year":"2021","unstructured":"Momin AA, Shao J, Soni P et al (2021) Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study. J Neurooncol 152(2):373\u2013382. https:\/\/doi.org\/10.1007\/s11060-021-03711-z","journal-title":"J Neurooncol\u00a0"},{"issue":"Suppl 3","key":"4878_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/jns.2004.101.supplement3.0390","volume":"101","author":"DC Shrieve","year":"2004","unstructured":"Shrieve DC, Hazard L, Boucher K, Jensen RL (2004) Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 101(Suppl 3):390\u2013395. https:\/\/doi.org\/10.3171\/jns.2004.101.supplement3.0390","journal-title":"J Neurosurg\u00a0"},{"issue":"2","key":"4878_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11060-021-03775-x","volume":"153","author":"S Oya","year":"2021","unstructured":"Oya S, Ikawa F, Ichihara N et al (2021) Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the brain tumor registry of Japan. J Neurooncol 153(2):351\u2013360. https:\/\/doi.org\/10.1007\/s11060-021-03775-x","journal-title":"J Neurooncol\u00a0"},{"issue":"1","key":"4878_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijrobp.2020.08.015","volume":"109","author":"G Lee","year":"2021","unstructured":"Lee G, Lamba N, Niemierko A et al (2021) Adjuvant radiation therapy versus surveillance after surgical resection of atypical meningiomas. Int J Radiat Oncol Biol Phys 109(1):252\u2013266. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"4878_CR17","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.21037\/cco.2017.06.09","volume":"6","author":"KL Hwang","year":"2017","unstructured":"Hwang KL, Hwang WL, Bussi\u00e8re MR, Shih HA (2017) The role of radiotherapy in the management of high-grade meningiomas. Chin Clin Oncol 6(Suppl 1):S5. https:\/\/doi.org\/10.21037\/cco.2017.06.09","journal-title":"Chin Clin Oncol"},{"key":"4878_CR18","doi-asserted-by":"publisher","first-page":"877244","DOI":"10.3389\/fonc.2022.877244","volume":"12","author":"HK Byun","year":"2022","unstructured":"Byun HK, Chang WI, Lee JH et al (2022) Adjuvant Radiotherapy Versus Surveillance for Grade 2 intracranial meningiomas: a multi-institutional propensity score-matched study. Front Oncol 12:877244. https:\/\/doi.org\/10.3389\/fonc.2022.877244","journal-title":"Front Oncol"},{"issue":"1","key":"4878_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-007-9338-y","volume":"84","author":"H Kano","year":"2007","unstructured":"Kano H, Takahashi JA, Katsuki T et al (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84(1):41\u201347. https:\/\/doi.org\/10.1007\/s11060-007-9338-y","journal-title":"J Neurooncol\u00a0"},{"key":"4878_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fonc.2013.00227","volume":"3","author":"BP Walcott","year":"2013","unstructured":"Walcott BP, Nahed BV, Brastianos PK, Loeffler JS (2013) Radiation treatment for WHO Grade II and III meningiomas. Front Oncol 3:227. https:\/\/doi.org\/10.3389\/fonc.2013.00227","journal-title":"Front Oncol\u00a0"},{"issue":"1","key":"4878_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13014-019-1368-z","volume":"14","author":"SM Hemmati","year":"2019","unstructured":"Hemmati SM, Ghadjar P, Gr\u00fcn A et al (2019) Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma. Radiat Oncol 14(1):160. https:\/\/doi.org\/10.1186\/s13014-019-1368-z","journal-title":"Radiat Oncol\u00a0"},{"issue":"2","key":"4878_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/s0360-3016(02)03809-9","volume":"55","author":"A Pirzkall","year":"2003","unstructured":"Pirzkall A, Debus J, Haering P et al (2003) Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys 55(2):362\u2013372. https:\/\/doi.org\/10.1016\/s0360-3016(02)03809-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4878_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","volume":"106","author":"CL Rogers","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA et al (2020) High-risk meningioma: initial outcomes from NRG Oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys 106(4):790\u2013799. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4878_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1748-717X-9-38","volume":"9","author":"DJ Ferraro","year":"2014","unstructured":"Ferraro DJ, Funk RK, Blackett JW et al (2014) A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Radiat Oncol 9:38. https:\/\/doi.org\/10.1186\/1748-717X-9-38","journal-title":"Radiat Oncol\u00a0"},{"issue":"6","key":"4878_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3171\/2013.8.JNS13343","volume":"119","author":"S Hanakita","year":"2013","unstructured":"Hanakita S, Koga T, Igaki H et al (2013) Role of gamma knife surgery for intracranial atypical (WHO grade II) meningiomas. J Neurosurg 119(6):1410\u20131414. https:\/\/doi.org\/10.3171\/2013.8.JNS13343","journal-title":"J Neurosurg\u00a0"},{"issue":"1","key":"4878_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10143-023-01969-7","volume":"46","author":"F Gagliardi","year":"2023","unstructured":"Gagliardi F, De Domenico P, Snider S et al (2023) Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis. Neurosurg Rev 46(1):71. https:\/\/doi.org\/10.1007\/s10143-023-01969-7","journal-title":"Neurosurg Rev"},{"issue":"1","key":"4878_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20(1):22\u201339. https:\/\/doi.org\/10.1136\/jnnp.20.1.22","journal-title":"J Neurol Neurosurg Psychiatry\u00a0"},{"key":"4878_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jocn.2017.08.023","volume":"46","author":"A Dohm","year":"2017","unstructured":"Dohm A, McTyre ER, Chan MD et al (2017) Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: clinical outcomes and local control. J Clin Neurosci 46:90\u201398. https:\/\/doi.org\/10.1016\/j.jocn.2017.08.023","journal-title":"J Clin Neurosci\u00a0"},{"key":"4878_CR29","doi-asserted-by":"publisher","DOI":"10.3171\/2020.6.JNS201904","author":"TH Schwartz","year":"2020","unstructured":"Schwartz TH, McDermott MW (2020) The Simpson grade: abandon the scale but preserve the message. J Neurosurg. https:\/\/doi.org\/10.3171\/2020.6.JNS201904","journal-title":"J Neurosurg"},{"key":"4878_CR30","volume-title":"Adult CNS Radiation Oncology","author":"TJ Harris","year":"2018","unstructured":"Harris TJ, Chao ST, Rogers CL (2018) Meningioma. In: Chang E, Brown P, Lo S, Sahgal A, Suh J (eds) Adult CNS Radiation Oncology. Springer, Cham"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04878-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04878-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:05:49Z","timestamp":1736766349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04878-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4878"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04878-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5189133\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Varun Kshettry is a consultant for Integra and Stryker. Pablo Recinos is a consultant for Stryker. Samuel Chao received honorariums from Varian Medical Systems and Blue Earth Diagnostics, as well as receives research support from Blue Earth Diagnostics. John Suh is consultant for Philips, Novocure, Neutron Therapeutics, and EmpNia. All other authors do not have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Cleveland Clinic Foundation Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}